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ABSTRACT The deoxyribonucleotide sequence of pyrB, the
cistron encoding the catalytic subunit of aspartate transcarbamo-
ylase (carbamoylphosphate:L-aspartate carbamoyltransferase, EC
2.1.3.2), has been determined. The pyrB gene encodes a poly-
peptide of 311 amino acid residues initiated by an NH2-terminal
methionine that is not present in the catalytically active polypep-
tide. The DNA sequence analysis revealed the presence of an eight-
amino-acid sequence beginning at Met-219 that was not detected
in previous analyses of amino acid sequence. This octapeptide se-
quence provides an additional component of the disordered loop
in the equatorial domain of the catalytic polypeptide. It had been
found previously that the catalytic polypeptide is expressed from
a bicistronic operon that also produces the regulatory polypeptide
encoded by pyrI. A single transcriptional control region precedes
the structural gene of the catalytic polypeptide and a simple 15-
base-pair region separates its COOH terminus from the structural
gene of the regulatory polypeptide. The chain-terminating codon
of the catalytic polypeptide may contribute to the ribosomal bind-
ing site for the regulatory polypeptide and thus assist coordinate
expression of the two cistrons.
The aspartate transcarbamoylase holoenzyme (ATCase; aspar-
tate carbamoyltransferase; carbamoylphosphate:L-aspartate
carbamoyltransferase, EC 2.1.3.2) is a dodecamer composed of
two catalytic trimers (c3) and three regulatory dimers (r2) (1).
This oligomer, 2(c3)'3(r2), is so arranged that each catalytic
monomer is in contact with three other catalytic chains and two
regulatory chains, while each regulatory monomer interfaces
with one other regulatory chain and two catalytic chains (2).
Perbal and Herv6 demonstrated that the two polypeptides are
produced in approximately balanced biosyntheses (3), and we
recently demonstrated that the two genes were closely linked
and encoded on a 6.0-kilobase (kb) fragment isolated from
AdargI'pyrB+ transducing phage obtained from N. Glansdorff
(4). The structural gene that encodes the catalytic polypeptide
was designated pyrB (5) and the structural gene encoding the
regulatory polypeptide has been designated pyrl (4, 6). Re-
cently, we demonstrated that pyrBI is organized as a bicistronic
operon possessing a single control region, which includes a p-
independent attenuator sequence, a region of dyad symmetry
overlapping transcriptional initiation, and a presumed leader
polypeptide whose termination overlaps the ribosomal binding
site for the translation of the catalytic polypeptide (7).
The architecture of ATCase from Escherichia coli has been
extensively examined because the regulatory controls that af-
fect the catalytic sites are mediated by distinct allosteric sites
located on separate regulatory polypeptides. ATCase catalyzes
the first reaction unique to pyrimidine biosynthesis, the con-
densation of carbamoyl phosphate and aspartate to produce car-
bamoyl-L-aspartate and orthophosphate (8). The enzyme is sub-ject to allosteric inhibition by CTP, one of the ultimate products
of pyrimidine ribonucleotide biosynthesis (9); in contrast, ATP
is a heterotropic activator of ATCase from E. coli (10) and com-
petes with CTP for the same binding sites on the regulatory
subunits (11). The appropriate heterotropic effects of these nu-
cleotide effectors occur as a consequence of conformational
changes (12, 13) in the multimeric enzyme that alter the homo-
tropic interactions of both substrates, aspartate and carbamoyl-
phosphate (9, 10). The kinetic and physical properties of native
ATCase holoenzyme and its constituent subunits from E. coli
have been extensively examined and atomic models describing
the biochemical and crystallographic structure continue to be
refined (14-16). The recent work of Honzatko et aL (2) rep-
resents the current state of the art. Nonetheless, the efforts to
describe the functional architecture of ATCase completely have
been hampered by the absence of a published amino acid se-
quence of the catalytic polypeptide (see ref. 17). The amino
acid sequence of the regulatory polypeptide was published by
Weber in 1968 (18). In this paper we report the nucleotide se-
quence of the structural gene for the catalytic polypeptide of
ATCase and the amino acid sequence deduced from the DNA
sequence.
MATERIALS AND METHODS
DNA Sequence Analysis. DNA fragments were isolated from
plasmid pPB-hlO5 (plasmid pyrimidine-B cistron holoenzyme
strain 105) by restriction endonuclease digestion followed by
electrophoresis on polyacrylamide gels as described (7). The
fragments were dephosphorylated with bacterial alkaline phos-
phatase and labeled at their 5' ends with [y-32P]ATP by utiliz-
ing phage T4 polynucleotide kinase as described by Maxam and
Gilbert (19). Sequence determination of appropriate overlap-
ping fragments was accomplished by using the C, C+T, A+G,
A>C, and G specific cleavages defined by Maxam and Gilbert
(19) except that the A+G reactions were performed at 370C as
modified by Smith and Calvo (20). Sequencing gels were pre-
pared as described by Maxam and Gilbert for 8% gels (19) and
by Smith and Calvo for 5% gels (20).
Materials. Restriction endonucleases were obtained from
Bethesda Research Laboratories, New England BioLabs, or
Boehringer Mannheim and used according to the suppliers'
recommendations. Bacterial alkaline phosphatase and T4 poly-
nucleotide kinase were purchased from Bethesda Research
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Laboratories and used as described by Maxam and Gilbert (19).
Biochemical reagents were purchased from New England Nu-
clear, Calbiochem-Behring, or Sigma.
Bacterial Strains and Plasmids. F'-plasmid DNA was pu-
rified from E. coli K-12 (KLF17/KL132) carrying F'117 (F'
pyrBI+ arg'), and recombinant DNA plasmids of various con-
struction were produced by ligation of appropriate restriction
fragments into pBR322 as described (7). Plasmids were main-
tained in E. coli TB2 (K-12 Aargl-pyrBI), which was derived
from the insertion and subsequent excision of phage Mu dl (lac
Ap) in pyrB of the E. coli K-12 chromosome according to the
procedures of Casadaban and Cohen (21). Bacterial culture,
plasmid isolation, and the preparation of cell-free extracts were
accomplished by standard procedures (7, 22). The plasmid used
in these studies is a 2.8-kb fragment of F'117 inserted into the
Sal I and Pst I sites of pBR322. This plasmid carries both pyrB
and pyrI with their complete control region (7) and produces
ATCase holoenzyme [Mr = 310,000; 2(c3).3(r2)] at approxi-
mately 20-fold higher levels than the K-12 parental strain. En-
zyme assays for ATCase in cell-free extracts and estimation of
molecular weights by ascending Sephadex G-200 chromatog-
raphy were performed by described methods (7, 22).
RESULTS AND DISCUSSION
Nucleotide Sequence. The pyrB cistron is located at ap-
proximately 96.0 min on the E. coli chromosome (5) and has
been mapped contiguous with pyrI and adjacent to argI with
approximately 3,000 base pairs separating the genes (Fig. 1).
The 2.8-kb fragment defined by the bracketed region bordered
by Pst I and Sal I sites contains the pyrBI operon and con-
trolling regions (7). The nucleotide sequence was determined
by the use of base-specific chemical modifications of small re-
striction fragments according to the scheme presented in Fig.
1. Previously, we determined the nucleotide sequence of the
200-base-pair promoter-leader region of pyrBI and the adja-
cent NH2-terminal portion of the catalytic polypeptide (7). Pauza
et aL (23) have recently determined the nucleotide sequence of
the COOH-terminal region of the catalytic polypeptide and the
intercistronic region and the NH2-terminal portion of the reg-
ulatory polypeptide. The total nucleotide sequence of pyrB,
including its putative ribosomal binding site for the catalytic
polypeptide, is shown in Fig. 2. The NH2 terminus of the cat-
alytic polypeptide was described by Gigot et aL in 1977 (24) as
Ala-Asn-Pro-Leu-Tyr-Gln-Lys-His-Ile-Ile . . ., and this se-
quence corresponded with the polypeptide sequence deduced
from the nucleotide sequence shown in Fig. 2. The DNA se-
quence predicted the translation of an NH2-terminal methio-
nine that was not present in the mature catalytic polypeptide
and the second residue (alanine) assumed that position. The size
of the polypeptide predicted from the nucleotide sequence was
311 amino acids, with an expected molecular mass of 34,074
daltons, including the NH2-terminal methionine, or 33,943 dal-
tons without that methionine. Those values correspond re-
markably well with the estimate of 35,000 daltons obtained by
physicochemical measurements of the purified polypeptide (25).
A comparison of the deduced amino acid sequence and the
proposed amino acid sequence of the initial catalytic polypep-
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FIG. 1. Restriction map and sequencing strategy for the analysis ofthe E. colipyrB cistron, which encodes the catalytic polypeptide of ATCase.
The appropriate region of the E. coli chromosome is represented at the top of the figure in approximate numbers of base pairs. An expanded re-
striction map is presented for the surrounding chromosomal region as subcloned on a 2.8-kb restriction fragment bordered by Pst I and Sal I sites.
Six different restriction endonuclease digests were used to develop the nucleotide sequence by the procedures ofMaxam and Gilbert (19) as described
in the text. A detailed restriction endonuclease map is defined by representing the size (in base pairs) of various restriction fragments within the
horizontal bar diagram. The vertical arrows indicate the specific locations of restriction sites. The horizontal arrows beneath the bar diagram dem-
onstrate the direction and length of various sequencing reactions.
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Si
TTT TGC CCA GGC GTC AGG AGA TAA AAG ATG GCT AAT CCG CTA TAT CAG AAAMCAT ATC ATT TCC'ATA AAC GAC CTT'AGT CGC GAT GAC CTT
(Met)AZa-Asn-Pro-Leu-Tyr-Gln-Lys-His-IZe-IZe-Ser-IZe-Asn-Asp-Leu-Ser-Arg-Asp-Asp-Leu-2o
Hi S2
AAT CTG GTG CTG GCG ACA GCG GCG AAA CTG AAA GCA AAC CCGFCAA CCA GAG CTG TTG AAG'CAC AAA GTC ATT GCC AGC TGT TTC TTC GAA'
Asn-Leu-Val-Leu-A la-Thr-Ala-A la-Lys-Leu-Lys-A Za-Asn-Pro-Gln-Pro-Glu-Leu-Leu-Lys-His-Lys-Val-Ile-AZa-Ser-'ys-Phe-Phe-Glu-5°
H2 S3
GCC TCT ACC CGT ACC CGC CTC TCT TTT CAA ACA TCT ATG CAC CGCTCTG GGG GCC AGC GTG GTG GGC TTC TCC'GAC AGC GCC MAT ACA TCA
A Aa-Ser-Thr-Arg-Thr-Arg-Leu-Ser-Phe-GZn-Thr-Ser-Met-His-Arg-leu-GZy-Asa-Ser-VaZ-VaZ-Ghy-Phe-Ser-Asp-Ser-AZa-Asn-Thr-Ser-80
H3 S4
CTG GGT AAA AAA GGC GAA'ACG CTT GCC GAT ACC.ATT TCA GTT ATC AGC ACT TACTGTCVGAT GCG ATA GTG ATG CGT CAT CCGVCAG GAAMGGT
Leu-GZy-Lys-Lys-Gly-Glu-Thr-Leu-AZa-Asp-Thr-IZe-Ser-Val-Ite-Ser-Thr-Tyr-VaZ-Asp-AZa-IZe-ViaZ-Met-Arg-His-Pro-GZn-GZu-Giy-11o
H4 S5 Turn H5
GCG GCG CGC CTG GCC ACC GAG TTT TCCVGGC AAT GTAVCCG GTA CTG AAT GCC GGTTGAT GGC TCC MCTCAM CAT CCGfACG CAA ACC TTG CTG
A Za-AZa-Arg-Leu-A Za-Thr-GZu-Phe-Ser-GZy-Asn-VaZ-Pro-VaZ-Leu-Asn-A Za-.GZy-Asp-GZy-Ser-Asn-GZn-His-Pro-Thr-GZn-Thr-Leu-Leu- 140
H5 --- Polar / Equatorial -- S6 H6
GAC TTA TTC ACT ATT CAG GAA ACC CAGVGGG CGT CTG GACTAAT CTC CAC GTC GCA ATG GTT GGT GACsCTG AAA TATTGGT CGC ACC GTT CAC
Asp-Leu-Phe-Thr-Iie-Gin-GZu-Thr-Gin-GZy-Arg-Leu-Asp-Asn-Leu-His-VaZ-A ia-Met-VaZ-GZy-Asp-Leu-Lys-Thr-GZy-Arg-Thr-VaZ-His-170
H6 S7 H7
TCC CTG ACT CAG GCG TTA GCT AAG TTC'GAC GGC AAC CGT TTT TAC TTC ATC GCG CCG'GAC GCG CTG GCA ATGvCCG CAA TAC ATT CTG GAT
Ser-Leu-Thr-GZn-AZa-Leu-Ala-Lys-Phe-Asp-GZy-Asn-Arg-Phe-Tyr-Phe-IZe-A Za-Pro-Asp-AZa-Leu-AZa-Met-Pro-GZn-Tyr-IZe-Leu-Asp-200
H7 S8 H? - Disordered Loop
ATG CTC GAT GMAAAMGGG ATC GCA TGG AGT CTG CAC AGC'TCT'ATT GAA GAA GTG ATG GTG GAA GTA GAC ATC CTG'TAC ATG ACC CGC GTG
Met-Leu-4sp-Glu-Lys-Giy-IZe-A ia-Trp-Ser-Leu-His-Ser-Ser-Iie-GZu-GZu-Vai-Met-Vai-GZu-VaZ-Asp-IZe-Leu-Tyr-Met-Thr-Arg-VaZ- 2 30
s9
TCAA AAA GAG CGT CTG GAC CCGFTCC GAG TAC GCC AAC GTG AAA GCG CAG TTT GTT CTT CGC GCC AGT GAT CTC CAC AAC GCC AAA GCCTMT
Gln-Lys-Glu-Arg-Leu-Asp-Pro-Ser-GZu-Tyr-A Za-Asn-VaZ-Lys-A Za-GZn-Phe-VaZ-Leu-Arg-A Za-Ser-Asp-Leu-His-Asn-Aia-Lys-Aia-Asn-2 60
.S10 strand H8 S1i H9
ATG AAA GTG CTG CAT CCGVTTG CCG CGT GTT GATIGAG ATT GCG ACG'CAT GTT'GAT AAA ACG CCA'CAC GCC TGGvTAC TTC CAG CAG GCA GGC
M>.e t-Lys-Vai-Leu-His -Pro -Leu-Pro-Arg-VaZ-Asp--Gu-IZe-Aia-Thr-Asp VaZ-Asp-Lys-Thr-Pro-His-AZa-Trp-Tyr-Phe-GZn-GZn-A Za-GZy-290
H9
MAC GGG ATT TTC GCT CTG CAA GCG TTA CTG GCA CTG GTT CTG AAT'CGC GAT CTG GTA CTG TAA GGG GAA ATA GAG ATG ACA CAC GAT AAT
Asn-Gly-Ile-Phe-Aia-Arg-Gln-AZa-Leu-Leu-AZa-Leu-VaZ-Leu-Asn-Arg-Asp-Leu-VaZ-Leu31o Met-Thr-His-Asp-Asn-
catalytic polypeptide regulatory polypeptide
FIG. 2. Nucleotide sequence of thepyrB gene and flanking regions. The DNA sequence was used to deduce the amino acid sequence of the cat-
alytic polypeptide of ATCase. The amino acid residues are numbered on the right side. The NH2 terminus of the regulatory polypeptide is depicted
on the last line, beginning with Met-Thr-His-Asp-Asn. The presumed ribosomal binding sites are indicated by solid lines drawn under the appro-
priate nucleotide sequences (line one and the last line represent the catalytic and regulatory sites, respectively). Brackets above the nucleotide
sequence are used to identify those regions that code for various a-helix and (-sheet regions of ATCase as identified by Monaco et al. (16) and Hon-
zatko et al. (2). The polar and equatorial domains of the enzyme are generally defined by the first and last half of the gene, respectively. (This
observation is indicated at nucleotide 510, corresponding to amino acid residues Gln-149-Gly-150.)
tide of ATCase determined by Edman degradation (17) re-
vealed the presence of an insert of eight amino acids at Met-
219. The octapeptide is bounded by Met-219 and Met-227 and
occupies the disordered loop of the catalytic polypeptide shown
in Fig. 3 at the top of the equatorial domain. This sequence,
219 22
Met-Val-Glu-Val-Asp-Ile-Leu-Tyr (Fig. 2), has a high proba-
bility of adopting an a-helical structure when analyzed accord-
ing to the assumptions of Chou and Fasman (26); however, that
helix does not appear in the equatorial domain (W. N. Lips-
comb, personal communication). Nonetheless, this addend is
located between (3-sheet structures termed S8 and S9 (see Fig.
3). Table 1 presents a comparison of the potential secondary
structures identified by Honzatko et al. (2) and the deduced se-
quence reported in Fig. 2. The preliminary amino acid primary
sequence (17) was assigned to the type of secondary structure
deduced from x-ray crystallographic analysis and the a-helical
structures and the (3-sheet regions ("strand," Sn). These are
identical through S8 (Gly-206 to Ser-213) until the disordered
loop containing the cryptic octapeptide sequence. After that
point the amino acid sequence and the requirements of the x-
ray crystallographic analyses began to diverge. In order to ap-
proximate the amino acid sequence to the atomic model of
ATCase based on approximation of a-carbon positions, Hon-
zatko et at (2) added three residues in numerical description
after residue 242. We have reassigned the strand and helix types
of secondary structure to their appropriate amino acid location
deduced from DNA sequence analysis.
Various studies have suggested a larger catalytic polypeptide
than previously thought. The unpublished primary sequence
from Konigsberg's laboratory has been frequently cited and
contained 302 amino acids. However, the analysis of the de-
duced amino acid sequence and the proposed secondary struc-
ture presented by Honzatko et aL (2) suggested that the poly-
peptide had to possess at least 305 amino acids. Landfear et at
(27) identified an 11-amino-acid sequence that seemed to cor-
respond to the amino acid residues Leu-208 to Lys-217 derived
from the sequence of Konigsberg and co-workers (reported as
a personal communication); however, this sequence actually
Proc. Nad Acad. Sci. USA 80 (1983)
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Equatorial Domain
Regulatory Catalytic
polypeptide polypeptide
216Glu-Glu-Val-Met-Val-Glu-Val-Asp-Ile-Leu-Tyr226
Ha -Ha -ha -ha -ha -Ha -ha -ia -Ia -Ha -ba
FIG. 3. Diagram of the structure of a single regulatory catalytic
unit as estimated from the a-carbon positions determined by electron
density analysis of x-ray crystallographic studies. This figure is mod-
ified from Honzatko et al. (2) with permission. The helices of the reg-
ulatory and catalytic polypeptides are represented by cylinders iden-
tified as H1'-H3' for the regulatory chain and H1-H9 for the catalytic
chain. The octapeptide whose presence was confirmed in these studies
is indicated as H? in the equatorial domain. Similarly, a-sheet regions
are represented as 1'-9' or 1-11. The various functional domains ofthe
enzyme are indicated. The potential helix formation for H? is indicated
beneath the diagram (26).
corresponded to Leu-235 to Lys-244 (Fig. 2). In addition, Wall
et at (28) identified the amino acid sequence of a 38-residue
peptide that did correspond with Leu-114 to Arg-151. These
observations are all consistent with the deduced amino acid se-
quence reported in this paper. Konigsberg and Henderson have
reevaluated their amino acid sequence data by using HPLC
separation and they have supported the deduced sequence (17).
The mature, catalytically active polypeptide of ATCase is com-
posed of 310 amino acids, with alanine serving as the NH2 ter-
minus and a potentially free-moving five-residue sequence (Arg-
Asp-Leu-Val-Leu) following helix 9 (H9; see Fig. 3) providing
the COOH terminus.
The actual DNA sequence of the COOH-terminal portion of
the catalytic cistron, intercistronic region, and NH2-terminal
portion of the regulatory cistron verified the reported partial
sequence of the region (23) and corresponded with the pub-
lished amino acid sequence of the regulatory polypeptide (18).
The nucleotide sequence of the COOH-terminal region (Asn-
260 to Gly-290) has been determined on only one strand.
Amino Acid Composition and Codon Usage. We have de-
termined the amino acid composition of the catalytic polypep-
tide and the distribution of residues by codon usage (data not
shown). The DNA sequence of the structural gene region of
pyrB is approximately 48% A+T, which is similar with the base
composition of the host E. coli K-12 (31). The pattern of codon
usage is comparable to that observed for a mixture of several
E. coli proteins as described by Greene et al. (30). Post and No-
mura have suggested that the ribosomal proteins utilize the ma-
jor tRNA species in order to allow the most efficient translation
of these abundant proteins (29). Similarly, it appears that the
catalytic cistron of ATCase utilized the most abundant species
Table 1. Comparison of secondary structure determined by
amino acid sequence and by nucleotide sequence
Type of Amino acid Location
Element secondary primary from nucleotide
name* structure* sequencet sequence*
Si Strand His-8-Ser-11 His-8-Ser-11
H1 Helix Ser-16-Pro-34 Ser-16-Pro-34
S2 Strand His4i-Glu-50 His-41-Glu-50
H2 Helix Ser-52-Arg-65 Ser-52-Arg-65
S3 Strand Leu-66-Ser-74 Leu-66-Ser-74
H3 Helix Thr-87-Tyr-98 Thr-87-Tyr-98
S4 Strand Asp-100-Pro-107 Asp-100-Pro-107
H4 Helix Gly-110-Ser-119 Gly-110-Ser-119
S5 Strand Pro-123-Gly-128 Pro-123-Gly-128
- Turn Asp-129-Asn-132 Asp-129-Asn-132
H5 Helix Thr-136-Glu-149 Thr-136-Gln-149
S6 Strand Asn-154-Asp-162 Asn-154-Asp-162
H6 Helix Gly-166-Phe-179 Gly-166-Phe-179
S7 Strand Asp-180-Pro-189 Asp-180-Pro-189
H7 Helix Pro-195-Glu-204 Pro-195-Glu-204
S8 Strand Gly-206-Ser-213 Gly-206-Ser-213
- Helix Ile-216-Arg-221 Ile-214-Leu-224
S9 Strand Gln-223-Pro-229 Gln-231-Pro-237
- Strand AA-244-AA-248
Sio Strand Asn-255-Pro-261 Asn-260-Pro-266
- Strand Glu-267-Thr-270 Glu-272-Thr-275
H8 Helix Asp-271-Pro-275 Asp-278-Pro-281
Sii Strand His-277-Trp-279 His-282-Trp-284
H9 Helix Tyr-280-Asn-300 Tyr-285-Asn-305
* From Honzatko et al. (2). "Strand" indicates ,-sheet and "Helix" rep-
resents a-helix (26).
tFrom the revised sequence of Konigsberg up to residue 242 as mod-
ified by Honzatko et al. (2).
tSee Fig. 2.
of tRNA, with the possible exception of AUA for isoleucine (3/
16 isoleucine codons represent minor species).
Ribosomal Binding Sites. Although the pyrB and pyrI gene
products are apparently expressed from a single mRNA, that
does not ensure their equivalent translation in order to provide
stoichiometric production of catalytic and regulatory polypep-
tides. Imamoto and Yanofsky (32) observed that the five gene
products of the trp operon of E. coli are normally synthesized
in equimolar amounts from its polycistronic message. How-
ever, Selker and Yanofsky (33) proposed that the observed
overlapping of stop and start codons of sequentially expressed
cistrons in the trp operon may provide a means for the trans-
lational coupling of expression. Furthermore, this might reflect
a general mechanism for the production of polypeptides re-
quired in equivalent amounts (34). The translational stop (UAA)
of the catalytic polypeptide was observed to overlap the ri-
bosomal binding site for the regulatory polypeptide and pro-
vides an analogous mechanism to trp expression, in which the
translational expression of the two cistrons may be clearly cou-
pled (23).
Conclusions. The complete amino acid sequence of the cat-
alytic polypeptide of ATCase has been derived from the DNA
sequence of a cloned pyrB gene from E. coli. The sequence has
been confirmed by comparison with previously published seg-
ments of the polypeptide (24, 27, 28) and the amino acid se-
quence generated by Konigsberg and Henderson (17). Our ini-
tial analysis revealed an undetected eight-amino-acid sequence
corresponding to residues Met-219 to Tyr-226. This sequence
appears to participate in a disordered loop assigned by Monaco
et al. (16) and Honzatko et aL (2) to the equatorial domain as
determined by x-ray structure analysis. The sequence allows
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the clarification of the regions involved in secondary structure
formation by Lipscomb and co-workers (11-13, 16).
The codons used for various amino acids are translated by
major species of isoaccepting tRNAs (29, 30). Thus it would seem
that the catalytic polypeptide would be rapidly translated if its
ribosomal binding site was accessible. Furthermore, the cata-
lytic polypeptide chain-terminating codon may participate in
the ribosomal binding site of the regulatory polypeptide. These
interactions might provide some modulation for the apparently
coordinate expression of pyrB and pyrl (3). The nature of the
regulatory controls affecting pyrBI expression invites further
analysis.
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